Latest From Biotech Now

Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?

Williams-headshot

In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first time provided for biosimilar or interchangeable biological drug products.  But it was not until March 6, 2015, that the FDA approved the first biosimilar application – an application by Sandoz to market a version of Amgen’s NEUPOGEN® (filgrastrim) biologic drug product.  Nevertheless, there is still a question as to when Sandoz will be able to begin selling its drug product, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

BIO Innovation Zone Company Snapshots: Protein Dynamic Solutions

BIO Innovation Zone

This month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Science Foundation (NSF) and the National Institutes of Health (NIH) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Maximize Your Savings Potential During BIO International Convention

BIO-Business-Solutions-Tagline

$161,000,000 That’s how much BIO saved life science companies in aggregate on their 2014 purchases of products and services. More than 2,800 companies nationwide participate in the industry’s largest cost savings program known as BIO Business Solutions®, by taking advantage of the program’s preferential pricing and other benefits. Find out how your company can save money and become a partaker by stopping by the Member Services Pavilion at booth #2001 during the convention. BIO’s Member Services Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Sen Menendez Asks SEC to Investigate IPR Abuses

Securities and Exchange Commission

New Jersey Senator Bob Menendez has asked the Securities and Exchange Commissioner (SEC) to investigate a new investment scheme designed to manipulate the stock prices of companies engaged in research and development of innovative medical therapies, to determine if the practice is illegal. As reported in this Bloomberg Business article, certain investment firms are shorting the stocks of patent-dependent life sciences companies and then using new patent litigation procedures to challenge their patents and drive Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

5 Days Until BIO 2015: Meet the Official Bloggers!

BIO Official Blogger

The 2015 BIO International Convention brings together biotech leaders, innovators and companies from across the world currently helping to transform the scientific landscape. The expert speakers and timely sessions are insightful and a great way to learn key industry takeaways and trends. It can be hard to keep track of everything going on at Convention and that is why we are working with bloggers and reporters who are covering events as they happen and can Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,